Drug Profile
GS 522
Latest Information Update: 15 May 2001
Price :
$50
*
At a glance
- Originator Gilead Sciences
- Class Antithrombotics; Nucleotides
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis